Tracking pregnancy outcomes in low-resource areas

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to quantify and analyze trends in pregnancy outcomes, such as stillbirths and maternal mortality, in low-resource geographic areas. By establishing a vital registry system, the study seeks to gather essential data on maternal and neonatal health, which is often lacking due to weak healthcare systems. Additionally, a sub-study will investigate the prevalence of COVID-19 among pregnant women and its impact on pregnancy outcomes. The findings will inform public health policies and interventions to improve maternal and child health in these communities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Community-level

  * Appropriate for long-term registry data collection and the conduct of ongoing Global Network research
  * At least 300 deliveries per year
* Participant-level

  * Pregnant women intending to deliver within study cluster
  * Women who deliver within the study cluster
  * Women who reside in the community but are transferred for care at delivery

Exclusion Criteria:

* Participant-level

  * Opt out of consent to include data in the study

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting
• University of Colorado Denver
  Aurora, Colorado, United States Recruiting
• Indiana University School of Medicine
  Indianapolis, Indiana, United States Recruiting
• Boston University
  Boston, Massachusetts, United States Recruiting
• Columbia University
  New York, New York, United States Recruiting
• University of North Carolina
  Chapel Hill, North Carolina, United States Recruiting

Study contacts

• Study coordinator: Marion Koso-Thomas, MD
• Email: marion.koso-thomas@nih.gov
• Phone: 301-435-6873

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Caffeine for Hypoxic Ischemic Encephalopathy in Newborns

  This trial tests whether giving caffeine to newborns with HIE helps reduce death or severe developmental problems by 18–22 months compared with a placebo.

  Recruiting at 3 sites Phase 3 NICHD Global Network for Women's and Children's Health · Saidpur and 6 other locations · NCT06855108

• Treating asymptomatic urinary infection during pregnancy in low- and middle-income countries

  This trial will test whether giving pregnant people with asymptomatic bacteriuria nitrofurantoin (versus placebo) can reduce preterm birth, small-for-gestational-age babies, or stillbirth.

  Recruiting at 2 sites Phase 3 NICHD Global Network for Women's and Children's Health · Dhaka, Bangladesh and 6 other locations · NCT06723392

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.